TOLREMO therapeutics' Spinoff / Spinout Round

TOLREMO therapeutics raised a round of funding on September 19, 2017. Investors include ETH Zurich.

TOLREMO therapeutics is working to discover and develop targeted therapeutics that will extend the lives of patients suffering from cancer.…

Articles about TOLREMO therapeutics' Spinoff / Spinout Round: